VALIDATION OF CNS-IPI AND CORRELATION WITH CELL OF ORIGIN PROFILE IN A RETROSPECTIVE SERIES OF DLBCL PATIENTS TREATED WITH R-CHOP IN A SINGLE INSTITUTION

被引：0
|
作者：
Castellino, A.
Novo, M.
Chiappella, A.
Ciochetto, C.
Vittone, F.
Botto, B.
Cavallo, F.
Orsucci, L.
Boccomini, C.
Evangelista, A.
Ghione, P.
Nicolosi, M.
Santambrogio, E.
Ciccone, G.
Novero, D.
Vitolo, U.
机构：
[1] Univ Torino, Ematol, Turin, Italy
[2] AOU Citta Salute & Sci, Anat Patol, Turin, Italy
[3] AOU Citta Salute & Sci, CPO, Epidemiol Clin, Turin, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P150
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [11] CNS Relapse Risk in Consecutive R-CHOP/R-Mini-CHOP-Treated Elderly DLBCL Is Low, with High Risk Particularly Apparent in Those with CNS IPI 5-6 and/or Renal/Adrenal Involvement
    Eyre, Toby A.
    Martinez-Calle, Nicolas
    Kirkwood, Amy A.
    Hildyard, Catherine
    Kesavan, Murali
    Butler, Joseph
    Mercer, Carolyn
    Djebbari, Faouzi
    Plaschkes, Hannah
    Griffith, John
    Booth, Stephen
    McMillan, Andrew
    Bishton, Mark
    Fox, Christopher P.
    Collins, Graham P.
    Hatton, Chris
    BLOOD, 2018, 132
  • [12] Prognostic significance of international prognostic index (IPI) individual risk factors in patients with diffuse large b cell lymphoma (DLBCL) treated with rituximab (R) and chop (R-CHOP) based chemotherapy
    Akhtar, S.
    Soudy, H.
    Darwish, A.
    Salam, M. Abdel
    Elhassan, T.
    Rehman, A.
    Bakshi, N.
    Maghfoor, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S847 - S847
  • [13] LYMPHOCYTOPENIA MAY ADD TO THE PREDICTION ACHIEVED BY THE REVISED INTERNATIONAL PROGNOSTIC INDEX (R-IPI) IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T.
    Anastasopoulou, A.
    Pangalis, G.
    Constantinou, N.
    Stavroulaki, E.
    Karakatsanis, S.
    Papageorgiou, S.
    Sachanas, S.
    Pappi, V.
    Tsirkinidis, P.
    Moschoyianni, M.
    Kyrtsonis, M.
    Kokoris, S.
    Kalpadakis, C.
    Siakantaris, M.
    Dimou, M.
    Georgiou, G.
    Konstantinidou, P.
    Dervenoulas, J.
    Roussou, P.
    Papadaki, H.
    Panayiotidis, P.
    Beris, P.
    Angelopoulou, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 280 - 280
  • [14] Prognostic Impact of Immunohistochemical Profile and Microvessel Density (MVD) in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
    Cardesa, T.
    Gutierrez-Garcia, G.
    Climent, F.
    Arenillas, L.
    Serrano, S.
    Romagosa, V.
    Gonzalez-Barca, E.
    Campo, E.
    Lopez-Guillermo, A.
    Colomo, Ll
    LABORATORY INVESTIGATION, 2009, 89 : 256A - 256A
  • [15] Prognostic Impact of Immunohistochemical Profile and Microvessel Density (MVD) in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
    Cardesa, T.
    Gutierrez-Garcia, G.
    Climent, F.
    Arenillas, L.
    Serrano, S.
    Romagosa, V.
    Gonzalez-Barca, E.
    Campo, E.
    Lopez-Guillermo, A.
    Colomo, L. I.
    MODERN PATHOLOGY, 2009, 22 : 256A - 256A
  • [16] External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival
    Warnnissorn, Naree
    Kanitsap, Nonglak
    Niparuck, Pimjai
    Boonsakan, Paisarn
    Kulalert, Prapasri
    Limvorapitak, Wasithep
    Bhoopat, Lantarima
    Saengboon, Supawee
    Chantrathammachart, Pichika
    Puavilai, Teeraya
    Chuncharunee, Suporn
    HEMATOLOGY, 2022, 27 (01) : 1237 - 1245
  • [17] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Hui, D.
    Proctor, B.
    Donaldson, J.
    Shenkier, T.
    Hoskins, P.
    Klasa, R.
    Savage, K.
    Gascoyne, R.
    Connors, J. M.
    Sehn, L. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 186 - 187
  • [18] Addition of Absolute Lymphocytes/Monocytes Ratio Improves the Revised-International Prognostic Index (R-IPI) in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP
    Bento, Leyre
    Maria Bautista-Gili, Antonia
    Garcia, Francesc
    Martinez-Serra, Jordi
    Garcia-Mano, Lucia
    Garcia-Redo, Marta
    Ballester, Carmen
    Gines, Jordi
    Lopez, Paloma
    Daumal, Jaime
    Ramos, Rafael
    Salar, Antonio
    Sampol, Antonia
    Besalduch, Juan
    Gutierrez, Antonio
    BLOOD, 2015, 126 (23)
  • [19] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Proctor, B. R.
    Hui, D.
    Donaldson, J.
    Savage, K. J.
    Shenkier, T. N.
    Hoskins, P. J.
    Klasa, R.
    Randy, G.
    Joseph, C.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [20] The influence of IPI, Ki67 and Bcl-2, on survival in patients with DLBCL treated with R-CHOP regimen - Serbian lymphoma study group experience
    Jovanovic, M. Perunicic
    Jakovic, Lj.
    Terzic, T.
    Gotic, M.
    Jankovic, S.
    Sretenovic, A.
    Petrovic, M.
    Boskovic, D.
    Mihaljevic, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 525 - 525
12345